| Pegaspargase - Wikipedia, the free encyclopedia Pegaspargase, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. It is used in ... Read More |
| Pegaspargase, Oncaspar, PEG-L-asparaginase - Chemotherapy Drugs ... Pegaspargase is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as an enzyme. Oncaspar, PEG-L-asparaginase Read More |
| pegaspargase medical facts from Drugs.com Physician reviewed pegaspargase patient information - includes pegaspargase description, dosage and directions. Read More |
| Pegaspargase: Information from Answers.com Pegaspargase Key Terms: Acute lymphocytic leukemia, Induction therapy. Definition Pegaspargase (also known as PEG-L-asparaginase and Oncaspar) is a medicine Read More |
| Oncaspar (Pegaspargase) Drug Information: Description, User ... Learn about the prescription medication Oncaspar (Pegaspargase), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Pegaspargase - National Cancer Institute - Comprehensive Cancer ... This page contains brief information about pegaspargase and a collection of links to more information about the use of this drug, research results, and ongoing ... Read More |
| Pegaspargase: MedlinePlus Drug Information Your doctor has ordered the drug pegaspargase to help treat your illness. The drug is given by injection into a large muscle or vein. This medication is ... Read More |
| Pegaspargase Facts and Comparisons at Drugs.com All about Pegaspargase. View complete and up to date Pegaspargase information - part of the Drugs.com trusted medication database. Read More |
| pegaspargase - MSN Health - Medications Pegaspargase is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. Pegaspargase is use Read More |
| FDA Approval for Pegaspargase - National Cancer Institute FDA Approval for Pegaspargase Brand name(s): Oncaspar® Approved for acute lymphoblastic leukemia; Full prescribing information is available, including clinical trial ... Read More |